Molecular and developmental mechanisms of congenital heart valve disease

Joy Lincoln1, Katherine E Yutzey

  • 1Department of Molecular and Cellular Pharmacology, Leonard M. Miller School of Medicine, University of Miami, 1400 Northwest 10th Avenue, Miami, FL, USA.

Insights

Congenital heart valve disease, including bicuspid aortic valve (BAV) and mitral valve prolapse (MVP), affects more individuals than previously thought. Understanding molecular pathways is key to developing new treatments beyond valve replacement.

Area of Science:

  • Cardiovascular Biology
  • Developmental Biology
  • Genetics

Background:

  • Congenital heart disease affects ~1% of live births, often involving heart valve abnormalities.
  • Conditions like bicuspid aortic valve (BAV) and mitral valve prolapse (MVP) manifest later, leading to progressive valve dysfunction.
  • Current treatment relies on valve replacement, with ~95,000 surgeries annually in the US.

Purpose of the Study:

  • To review the molecular regulatory pathways controlling heart valve development.
  • To explore how these pathways contribute to congenital valve disease.
  • To discuss the therapeutic implications of this understanding.

Main Methods:

  • Review of current literature on heart valve development and disease.
  • Analysis of findings from murine and avian model systems.
  • Inclusion of human genetic linkage studies.

Main Results:

  • Identified genes and regulatory processes implicated in valve structural malformations.
  • Highlighted abnormal valve cusp morphogenesis (e.g., BAV) and extracellular matrix (ECM) defects (e.g., MVP) as key issues.
  • Emphasized the largely unknown etiology of common congenital valve diseases.

Conclusions:

  • Molecular regulatory pathways are crucial in heart valve development and disease.
  • Further research into these pathways offers potential for novel therapeutic strategies.
  • Understanding genetic and regulatory factors is essential for addressing congenital valve disease.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...